KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Depreciation and Depletion: 2010-2014

Historic Depreciation and Depletion for Supernus Pharmaceuticals (SUPN) over the last 5 years, with Dec 2014 value amounting to $699,000.

  • Supernus Pharmaceuticals' Depreciation and Depletion fell 9.09% to $160,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $670,000, marking a year-over-year increase of 3.88%. This contributed to the annual value of $699,000 for FY2014, which is 36.52% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Depreciation and Depletion stood at $699,000 for FY2014, which was up 36.52% from $512,000 recorded in FY2013.
  • In the past 5 years, Supernus Pharmaceuticals' Depreciation and Depletion ranged from a high of $959,000 in FY2010 and a low of $512,000 during FY2013.
  • Its 3-year average for Depreciation and Depletion is $617,667, with a median of $642,000 in 2012.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first tumbled by 32.22% in 2011, then soared by 36.52% in 2014.
  • Supernus Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $959,000 in 2010, then plummeted by 32.22% to $650,000 in 2011, then fell by 1.23% to $642,000 in 2012, then declined by 20.25% to $512,000 in 2013, then soared by 36.52% to $699,000 in 2014.